
News|Articles|October 1, 2007
First-time generic approvals, October 2007
First-time generic approvals: Carvedilol tablets; famciclovir tablets
Advertisement
Key Points
Carvedilol tablets, 3.125, 6.25, 12.5, and 25 mg (equiv to Coreg tablets)
ACTAVIS ELIZABETH, APOTEX, AUROBINDO, CARACO, DR. REDDY'S, GLENMARK, LUPIN, MYLAN, RANBAXY, SANDOZ, TARO, TEVA, WATSON, ZYDUS
Famciclovir tablets, 125, 250, and 500 mg (equiv to Famvir tablets)
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Biosimilars in 2025: A year of firsts
2
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5






















































